A previous study found a reduction of 73% in survival in CRC cell lines (LoVo) after treatment with AG14361, a potent small molecule PARP1 inhibitor, when combined with 8 Gy of IR [110]. This evidence concerns the gene PARP1 and colorectal carcinoma.